Literature DB >> 9015415

Synthesis of TNF alpha and TGF beta mRNA in the different micro-environments within atheromatous plaques.

N B Rayment1, E Moss, L Faulkner, P M Brickell, M J Davies, N Woolf, D R Katz.   

Abstract

OBJECTIVE: To examine localisation of tumour necrosis factor (TNF alpha) and transforming growth factor beta (TGF beta) mRNA synthesis in human coronary artery atheromatous plaques, to explore how synthesis of these cytokines relates to distribution of macrophages and smooth muscle cells, and to correlate this with plaque micro-environments.
METHOD: In situ hybridisation with digoxigenin-labelled sense and anti-sense riboprobes was used, combined with immunohistochemistry to detect TNF alpha protein, macrophage, lymphocyte and smooth muscle cell markers.
RESULTS: In the intimal plaque TNF alpha mRNA is synthesised by monocytes/macrophages as well as by smooth muscle cells. Both TNF alpha and TGF beta mRNAs were present at the margins of the lesions and in reactive areas, where there was little lipid and fibrosis. Focal aggregates of macrophages in the adventitia expressed both TNF alpha mRNA and protein and TGF beta mRNA.
CONCLUSION: Synthesis of these two cytokines by macrophages as well as smooth muscle cells contributes to the pathobiology of the plaque and that this is part of the 'reaction to injury', rather than a feature of a specific cell, or a specific layer, within the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9015415     DOI: 10.1016/s0008-6363(96)00145-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

1.  TREM-1 is a positive regulator of TNF-α and IL-8 production in U937 foam cells.

Authors:  Yu-Shi Wang; Xiang-Jun Li; Wai-Ou Zhao
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

Review 2.  What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

Authors:  W G Dixon; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2007-01-24       Impact factor: 19.103

3.  Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.

Authors:  Daniel H Solomon; Jeffrey R Curtis; Kenneth G Saag; Joyce Lii; Lang Chen; Leslie R Harrold; Lisa J Herrinton; David J Graham; Mary K Kowal; Bindee Kuriya; Liyan Liu; Marie R Griffin; James D Lewis; Jeremy A Rassen
Journal:  Am J Med       Date:  2013-08       Impact factor: 4.965

4.  Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.

Authors:  Ravinder Tammali; Ashish Saxena; Satish K Srivastava; Kota V Ramana
Journal:  Endocrinology       Date:  2010-03-22       Impact factor: 4.736

5.  Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.

Authors:  Lennart T H Jacobsson; Carl Turesson; Jan-Ake Nilsson; Ingemar F Petersson; Elisabet Lindqvist; Tore Saxne; Pierre Geborek
Journal:  Ann Rheum Dis       Date:  2006-12-11       Impact factor: 19.103

6.  NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site.

Authors:  Da Lin; Hayley Lavender; Elizabeth J Soilleux; Christopher A O'Callaghan
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

Review 7.  Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke.

Authors:  Charles C Esenwa; Mitchell S Elkind
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

Review 8.  Implications of autophagy for vascular smooth muscle cell function and plasticity.

Authors:  Joshua K Salabei; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2013-08-09       Impact factor: 7.376

9.  Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.

Authors:  Jenny Persson; Jan Nilsson; Marie W Lindholm
Journal:  Lipids Health Dis       Date:  2006-06-26       Impact factor: 3.876

Review 10.  Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases.

Authors:  Eunhye Ji; Sahmin Lee
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.